Page last updated: 2024-08-16

mitomycin and fr 66973

mitomycin has been researched along with fr 66973 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Manda, T; Masuda, K; Matsumoto, S; Mori, J; Nakamura, T; Oku, T; Shimomura, K1
Hattori, Y; Hirai, O; Mine, Y; Miyamae, Y; Miyamoto, A; Takashima, M; Zaizen, K1
Inami, M; Kawamura, I; Manda, T; Matsumoto, S; Miyayasu, K; Naoe, Y; Nishigaki, F; Shimomura, K; Tsujimoto, S1

Other Studies

3 other study(ies) available for mitomycin and fr 66973

ArticleYear
Effect of FK973, a new antitumor antibiotic, on the cell cycle of L1210 cells in vitro.
    Japanese journal of pharmacology, 1989, Volume: 49, Issue:3

    Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cell Division; Cytarabine; DNA, Neoplasm; Flow Cytometry; Leukemia L1210; Mitomycin; Mitomycins; Mitosis; Oxazines; Time Factors; Vinblastine

1989
Microbial mutagenicity and in vitro chromosome aberration induction by FK973, a new antitumor agent.
    Mutation research, 1994, Volume: 324, Issue:1-2

    Topics: Animals; Antineoplastic Agents; Biotransformation; Cells, Cultured; Chromosome Aberrations; Cricetinae; Cricetulus; Mitomycin; Mutagenicity Tests; Mutation; Oxazines; Salmonella typhimurium

1994
FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome.
    Cancer chemotherapy and pharmacology, 1998, Volume: 42, Issue:1

    Topics: Animals; Antineoplastic Agents; Capillary Leak Syndrome; Drug Screening Assays, Antitumor; Female; Male; Mice; Mice, Inbred Strains; Mitomycin; Neoplasms, Experimental; Oxazines; Pleural Effusion; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured

1998